Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 11/20 | 0.47 |
| ▸ | DHFR | P00374 | 1/20 | 0.45 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13338150 | 0.83 | SIGMAR1 (0.45) | SIGMAR1DHFRHPRT1MCL1CYP1A2 | |
| SCHEMBL1683320 | 0.83 | SIGMAR1 (0.63) | SIGMAR1DHFRMCL1CYP1A2CYP2D6 | |
| SCHEMBL13338151 | 0.78 | SIGMAR1 (0.46) | SIGMAR1DHFRHPRT1MCL1CYP1A2 | |
| SCHEMBL12258286 | 0.75 | SIGMAR1 (0.50) | SIGMAR1DHFRHPRT1MCL1CYP1A2 | |
| SCHEMBL13338152 | 0.75 | SIGMAR1 (0.50) | SIGMAR1DHFRMCL1CYP1A2CYP2D6 | |
| SCHEMBL15787133 | 0.74 | CYP2A6 (0.56) | SIGMAR1DHFRMCL1CYP1A2CYP2D6 | |
| SCHEMBL13338153 | 0.74 | SIGMAR1 (0.49) | SIGMAR1DHFRCYP1A2CYP2D6CYP2C19 | |
| SCHEMBL15856551 | 0.72 | MCL1 (0.40) | SIGMAR1MCL1CYP1A2CYP2C19 | |
| SCHEMBL15856432 | 0.72 | MCL1 (0.40) | SIGMAR1DHFRMCL1CYP2C19 | |
| SCHEMBL1414206 | 0.72 | SIGMAR1 (0.57) | SIGMAR1DHFRCYP1A2CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8680336-B2 | Dyes for dye sensitized solar cell | LG DISPLAY CO., LTD. (KR) | 2014-03-25 | — | — | US | disclosed |
| US-8680336-B2 | Dyes for dye sensitized solar cell | LG DISPLAY CO., LTD. (KR) | 2014-03-25 | — | — | US | disclosed |
| US-20100126563-A1 | Dyes for dye sensitized solar cell | LG DISPLAY CO., LTD. (KR) | 2010-05-27 | — | — | US | disclosed |
| US-20100126563-A1 | Dyes for dye sensitized solar cell | LG DISPLAY CO., LTD. (KR) | 2010-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100126563-A1 | Dyes for dye sensitized solar cell | TYR, XPA, PAH | SIGMAR1 2130/4885DHFR 1953/4885HPRT1 1058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.